• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

拉丁美洲急性早幼粒细胞白血病的治疗:国际白血病联盟经验教训

Treating acute promyelocytic leukaemia in Latin America: lessons from the International Consortium on Acute Leukaemia experience.

作者信息

Corrêa de Araujo Koury Luisa, Ganser Arnold, Berliner Nancy, Rego Eduardo M

机构信息

Department of Internal Medicine, Medical School of Ribeirão Preto, and Centre for Cell-Based Therapy, University of São Paulo, Ribeirao Preto, SP, Brazil.

Department of Haematology, Haemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.

出版信息

Br J Haematol. 2017 Jun;177(6):979-983. doi: 10.1111/bjh.14589. Epub 2017 May 3.

DOI:10.1111/bjh.14589
PMID:28466545
Abstract

The Latin Americas and Caribbean are regions where social exclusion and inequality persist as the main obstacles to human development and improvement of health conditions, despite economic growth and social development. These countries need to establish international collaborations with the goal of improving health conditions. In this scenario Acute Promyelocytic Leukaemia (APL), a disease with a high cure rate in developed countries and high prevalence in young patients, offers an ideal opportunity to implement measures with educational and cooperative scope. We discuss the experience of Latin America and the Caribbean through a common network, the International Consortium on Acute Promyelocytic Leukaemia (IC-APL).

摘要

拉丁美洲和加勒比地区是这样的区域

尽管有经济增长和社会发展,但社会排斥和不平等依然是人类发展和健康状况改善的主要障碍。这些国家需要建立旨在改善健康状况的国际合作关系。在这种情况下,急性早幼粒细胞白血病(APL),一种在发达国家治愈率高且在年轻患者中患病率高的疾病,为实施具有教育和合作范畴的措施提供了理想机会。我们通过一个共同的网络——国际急性早幼粒细胞白血病联盟(IC - APL)来探讨拉丁美洲和加勒比地区的经验。

相似文献

1
Treating acute promyelocytic leukaemia in Latin America: lessons from the International Consortium on Acute Leukaemia experience.拉丁美洲急性早幼粒细胞白血病的治疗:国际白血病联盟经验教训
Br J Haematol. 2017 Jun;177(6):979-983. doi: 10.1111/bjh.14589. Epub 2017 May 3.
2
The impact of medical education and networking on the outcome of leukemia treatment in developing countries. The experience of International Consortium on Acute Promyelocytic Leukemia (IC-APL).医学教育与交流网络对发展中国家白血病治疗结果的影响。急性早幼粒细胞白血病国际联盟(IC-APL)的经验。
Hematology. 2012 Apr;17 Suppl 1:S36-8. doi: 10.1179/102453312X13336169155376.
3
Treatment of acute promyelocytic leukaemia with all-trans retinoic acid and arsenic trioxide: a paradigm of synergistic molecular targeting therapy.全反式维甲酸和三氧化二砷治疗急性早幼粒细胞白血病:协同分子靶向治疗的范例
Philos Trans R Soc Lond B Biol Sci. 2007 Jun 29;362(1482):959-71. doi: 10.1098/rstb.2007.2026.
4
Improving acute promyelocytic leukemia (APL) outcome in developing countries through networking, results of the International Consortium on APL.通过建立网络改善发展中国家的急性早幼粒细胞白血病(APL)预后:国际 APL 联盟的研究结果。
Blood. 2013 Mar 14;121(11):1935-43. doi: 10.1182/blood-2012-08-449918. Epub 2013 Jan 14.
5
All-trans retinoic acid with daunorubicin or idarubicin for risk-adapted treatment of acute promyelocytic leukaemia: a matched-pair analysis of the PETHEMA LPA-2005 and IC-APL studies.全反式维甲酸联合柔红霉素或伊达比星用于急性早幼粒细胞白血病的风险适应性治疗:PETHEMA LPA - 2005和IC - APL研究的配对分析
Ann Hematol. 2015 Aug;94(8):1347-56. doi: 10.1007/s00277-015-2393-0. Epub 2015 May 15.
6
Synergistic targeted therapy for acute promyelocytic leukaemia: a model of translational research in human cancer.协同靶向治疗急性早幼粒细胞白血病:人类癌症转化研究的典范。
J Intern Med. 2015 Dec;278(6):627-42. doi: 10.1111/joim.12376. Epub 2015 Jun 9.
7
Management of APL in developing countries: epidemiology, challenges and opportunities for international collaboration.发展中国家急性早幼粒细胞白血病的管理:流行病学、挑战及国际合作机遇
Hematology Am Soc Hematol Educ Program. 2006:162-8. doi: 10.1182/asheducation-2006.1.162.
8
Internal tandem duplication of the FLT3 gene confers poor overall survival in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based chemotherapy: an International Consortium on Acute Promyelocytic Leukemia study.FLT3 基因内部串联重复导致接受全反式维甲酸和蒽环类化疗治疗的急性早幼粒细胞白血病患者总体生存不良:急性早幼粒细胞白血病国际联合会研究。
Ann Hematol. 2014 Dec;93(12):2001-10. doi: 10.1007/s00277-014-2142-9. Epub 2014 Jul 2.
9
Curing APL in Latin America: more than just ATRA.在拉丁美洲治愈急性早幼粒细胞白血病:不仅仅是使用全反式维甲酸。
Blood. 2024 Sep 19;144(12):1237-1238. doi: 10.1182/blood.2024025429.
10
Induction, consolidation, and maintenance therapies with arsenic as a single agent for acute promyelocytic leukaemia in a 11-year follow-up.单药砷剂用于急性早幼粒细胞白血病的诱导、巩固及维持治疗:11年随访研究
Hematol Oncol. 2017 Mar;35(1):113-117. doi: 10.1002/hon.2253. Epub 2015 Aug 27.

引用本文的文献

1
Acute Promyelocytic Leukemia Asian Consortium study of arsenic trioxide in newly diagnosed patients: impact and outcome.急性早幼粒细胞白血病亚洲协作组关于三氧化二砷用于新诊断患者的研究:影响与结果
Blood Adv. 2025 Feb 25;9(4):862-876. doi: 10.1182/bloodadvances.2024014999.
2
The Consortium on Newborn Screening in Africa for sickle cell disease: study rationale and methodology.非洲新生儿镰状细胞病筛查联盟:研究背景与方法。
Blood Adv. 2022 Dec 27;6(24):6187-6197. doi: 10.1182/bloodadvances.2022007698.
3
Access to Therapy for Acute Myeloid Leukemia in the Developing World: Barriers and Solutions.
发展中国家急性髓细胞白血病治疗的可及性:障碍与解决方案。
Curr Oncol Rep. 2020 Oct 6;22(12):125. doi: 10.1007/s11912-020-00987-8.
4
Acute Promyelocytic Leukemia: A History over 60 Years-From the Most Malignant to the most Curable Form of Acute Leukemia.急性早幼粒细胞白血病:60 多年的历程——从最恶性的急性白血病形式到最可治愈的形式
Oncol Ther. 2019 Jun;7(1):33-65. doi: 10.1007/s40487-018-0091-5. Epub 2019 Feb 5.
5
Myeloid sarcoma of the tongue as a first manifestation of acute promyelocytic leukemia: A case report.舌部髓系肉瘤作为急性早幼粒细胞白血病的首发表现:一例病例报告。
Rep Pract Oncol Radiother. 2020 Mar-Apr;25(2):174-177. doi: 10.1016/j.rpor.2019.12.026. Epub 2020 Jan 9.